Spesolimab
Boehringer Ingelheim
['spesolimab', 'psoriasis']
congress #wcd2023singapore | late-breaker | presented a phase ii study of spesolimab for the prevention of generalized pustular #psoriasis flares. high-dose spesolimab was superior to placebo in preventing flares, with an 84% reduction in the risk of flare 
The Psoriasis and Psoriatic Arthritis Hub is an open-access online resource that provides balanced and up-to-date medical education. #Psoriasis #RheumTwitter